Wyeth Plans Tygacil Filing For CAP In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Wyeth will move ahead with tigecycline regulatory filing though the antibiotic failed to show superiority to J&J's Levaquin in Phase III trials.